Ranked by engagement
Top topics — all time page 27
Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,535 topics · page 27 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
About the Storage & stability category
Refrigeration, excursions, light exposure, freeze-thaw, beyond-use dating, and what published stability data actually covers. This post is a community wiki: any member at trust level 3 or above can edit it,…
|
4 | 57k | 4mo | |
|
How shortages have affected compounding permissions — does this still hold?
How shortages have affected compounding permissions — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. A coverage question with the paperwork…
|
+27 | 31 | 21k | 17h |
|
SNAC and the mechanism of oral peptide absorption — the long version
SNAC and the mechanism of oral peptide absorption — the long version Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J Med , 2024) cited in…
|
+32 | 36 | 6.8k | 16mo |
|
About the Home & field testing category
What consumer-accessible tests can and cannot tell you. Mostly a subcategory about limitations. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with…
|
4 | 51k | 11mo | |
|
What a stability-indicating method is and how you demonstrate one
Asking directly, because I could not find a straight answer: What a stability-indicating method is and how you demonstrate one Working through the identity arithmetic and I would like it checked. retatrutide…
|
4 | 57k | 6mo | |
|
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still hold?
Asking directly, because I could not find a straight answer: Air bubbles in a subcutaneous injection: the honest risk assessment — does this still hold? Reporting something rather than asking about it, in…
|
+21 | 30 | 20k | 4mo |
|
Reconstituting a multi-strength kit without mixing yourself up — what changed since
On the subject in the title: Reconstituting a multi-strength kit without mixing yourself up — what changed since Working notes rather than a conclusion. Practical question with the units stated, because I…
|
+42 | 46 | 1k | 7h |
|
Trial registration and comparing the protocol with the paper
Trial registration and comparing the protocol with the paper — setting out what I have, and where I think it stops being reliable. I have seen LEADER ( N Engl J Med , 2016) cited in support of a claim I do…
|
+38 | 44 | 4.8k | 10mo |
|
[2026 update] EU-wide position versus national implementation
On the subject in the title: EU-wide position versus national implementation Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of…
|
2 | 54k | 19mo | |
|
About the Red flags category
Patterns that reliably precede a problem. Documented, dated, and free of accusation without evidence. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
|
4 | 57k | 17mo | |
|
Athletes in weight-category sports: a different risk calculus
Athletes in weight-category sports: a different risk calculus — setting out what I have, and where I think it stops being reliable. General question, not a request for advice about my own care — I know the…
|
+38 | 42 | 6.6k | 1d |
|
Signs of dehydration worth acting on
Signs of dehydration worth acting on — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in this class mostly…
|
+34 | 38 | 5.9k | 21mo |
|
Splitting an overlong document into two
Posting this under the heading it deserves: Splitting an overlong document into two Everything below is what sits behind that. Nominating something for promotion into the documentation commons. The topic in…
|
+30 | 34 | 6.2k | 1d |
|
Revisiting: Sample size in a voluntary survey: the selection problem
Revisiting: Sample size in a voluntary survey: the selection problem — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three replies…
|
2 | 56k | 9mo | |
|
Import rules for personal quantities, by jurisdiction, dated
On the subject in the title: Import rules for personal quantities, by jurisdiction, dated Working notes rather than a conclusion. Structured report rather than an opinion, following the format the maintainers…
|
3 | 60k | 12mo | |
|
What would change my mind about repair peptides: a specific answer — one year on
What would change my mind about repair peptides: a specific answer — one year on I have a specific reason for asking rather than idle curiosity, and the context is below. Session topic: STEP 1 ( N Engl J Med…
|
+9 | 13 | 42k | 19mo |
|
Persistent vomiting and the threshold for seeking help — one year on
Persistent vomiting and the threshold for seeking help — one year on Writing it up because I had to work it out twice and would rather nobody else did. General question, not a request for advice about my own…
|
+39 | 43 | 596 | 19mo |
|
Cross-border purchase within the EU: the actual rules
Cross-border purchase within the EU: the actual rules Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is…
|
+6 | 10 | 41k | 11mo |
|
Canadian access and provincial variation — one year on
Canadian access and provincial variation — one year on Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this…
|
+43 | 47 | 964 | 12mo |
|
Reused chromatograms across lots: how to spot it — what changed since
Reused chromatograms across lots: how to spot it — what changed since — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a…
|
+34 | 39 | 20k | 2mo |
|
About the Datasets category
Community-collected datasets, their collection methods, and their limitations. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a…
|
+6 | 11 | 42k | 12mo |
|
[2026 update] What a good consultation looks like from the other side
The question in the title: What a good consultation looks like from the other side I will give what I have already checked below so nobody repeats it. Asking about a population rather than about a person. The…
|
+32 | 36 | 13k | 1mo |
|
DXA precision and the least significant change for lean mass — what changed since
DXA precision and the least significant change for lean mass — what changed since — setting out what I have, and where I think it stops being reliable. Maintenance rather than loss, which is the part of this…
|
2 | 56k | 11mo | |
|
[2026 update] Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA
Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA — setting out what I have, and where I think it stops being reliable. I have seen STEP 4 ( JAMA , 2021) cited in support of a claim I do not think…
|
2 | 58k | 11mo | |
|
Revisiting: Reading order for a first week here, and what to skip until later
Posting this under the heading it deserves: Revisiting: Reading order for a first week here, and what to skip until later Everything below is what sits behind that. I want to check my reasoning rather than…
|
2 | 60k | 4mo | |
|
Journal club: how we handle discontinuation in obesity trials — what changed since
Journal club: how we handle discontinuation in obesity trials — what changed since — setting out what I have, and where I think it stops being reliable. Session topic: STEP 4 ( JAMA , 2021). Please read it…
|
+14 | 18 | 35k | 8mo |
|
Revisiting: The arithmetic of an intermediate dose between two label steps
Revisiting: The arithmetic of an intermediate dose between two label steps Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
|
+41 | 45 | 808 | 2mo |
|
Revisiting: Mobile reading experience on long topics
Posting this under the heading it deserves: Revisiting: Mobile reading experience on long topics Everything below is what sits behind that. Nominating something for promotion into the documentation commons.…
|
+11 | 15 | 34k | 10h |
|
When a dose reduction is the correct response to a side effect
When a dose reduction is the correct response to a side effect — that is the question, and I have not found it answered plainly anywhere I have looked. A question about technique rather than about dose. I…
|
+38 | 42 | 2.7k | 19h |
|
Contributing data without breaching anyone's privacy — what changed since
On the subject in the title: Contributing data without breaching anyone's privacy — what changed since Working notes rather than a conclusion. A documentation question rather than an analytical one. I have a…
|
2 | 58k | 17mo |